Media Summary: Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ... In this video, Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses the ... James Blachly, MD, The Ohio State University, Columbus, OH, discusses measurable residual disease (
Methods To Evaluate Mrd In - Detailed Analysis & Overview
Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ... In this video, Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses the ... James Blachly, MD, The Ohio State University, Columbus, OH, discusses measurable residual disease ( Sylvie Freeman, MBChB, MRCP, DPhil, FRCPath, University of Birmingham, Birmingham, UK, comments on the Jill Corre, PharmD, PhD, of L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, ... Jerald P. Radich, MD, member, Clinical Research Division, Kurt Enslein Endowed Chair, Fred Hutchinson Cancer Research ...
Hervé Avet-Loiseau, MD, PhD, Cancer Research Center of Toulouse, Toulouse, France, summarizes the comparison of ... Jesús San Miguel, MD, PhD, University of Navarra, Pamplona, Spain, discusses the importance of using measurable residual ... Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses different
